2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
60
Head and Neck Neoplasms
22
Squamous Cell Carcinoma of Head and Neck
21
Lung Neoplasms
20
Carcinoma, Non-Small-Cell Lung
20
Colorectal Neoplasms
19
Melanoma
17
Colonic Neoplasms
16
Rectal Neoplasms
15
Carcinoma, Renal Cell
13
Pancreatic Neoplasms
12
Lymphoma
12
Prostatic Neoplasms
11
Ovarian Neoplasms
11
Lymphoma, Follicular
11
Carcinoma, Ovarian Epithelial
11
Kidney Neoplasms
9
Breast Neoplasms, Male
9
Salivary Gland Neoplasms
8
Lymphoma, Large B-Cell, Diffuse
8
Central Nervous System Neoplasms
8
Sarcoma
7
Liver Neoplasms
7
Esophageal Neoplasms
7
Uterine Cervical Neoplasms
6
Urinary Bladder Neoplasms
6
Unspecified Adult Solid Tumor, Protocol Specific
6
Neuroblastoma
6
Lymphoma, Large-Cell, Anaplastic
6
Lymphoma, B-Cell, Marginal Zone
6
Interventions
Carboplatin
7
Trastuzumab
6
Docetaxel
5
pembrolizumab
4
Paclitaxel
4
Oxaliplatin
4
Fluorouracil
4
Cytarabine
4
Cyclophosphamide
4
Azacitidine
4
pertuzumab
3
Radiotherapy
3
Observation
3
Neoadjuvant Therapy
3
Epirubicin
3
Endoscopy
3
Cisplatin
3
Chemoradiotherapy
3
Capecitabine
3
venetoclax
2
toripalimab
2
sargramostim
2
olaparib
2
durvalumab
2
cc-486
2
Tretinoin
2
Surgical Procedures, Operative
2
Standard of Care
2
Pemetrexed
2
Monatide (IMS 3015)
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
Immunohistochemistry
×
Clear all
NCT04917263
2021-06-08
IMMUNOREACT2
University of Padova
Unknown
544 enrolled